Progressive disseminated aspergillosis in a bone marrow transplant recipient: response with a high-dose lipid formulation of amphotericin B.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Volumn 32, Issue 5, 2001, Pages

  Kontoyiannis, D P ^a   Andersson, B S ^a   Lewis, R E ^a   Raad, I I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ITRACONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; CASE REPORT; DRUG COMBINATION; GRAFT VERSUS HOST REACTION; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; TREATMENT OUTCOME;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; DRUG THERAPY, COMBINATION; GRAFT VS HOST DISEASE; HUMANS; ITRACONAZOLE; MALE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 18044401452     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319208     Document Type: Article

References (0)